Medipost, OmniaBio to enhance cooperation for CDMO business

Medipost, OmniaBio to enhance cooperation for CDMO business

South Korea's stem-cell therapy company Medipost announced on Thursday that its Canadian affiliate OmniaBio made a two-day visit to South Korea on N...

Medipost to expand CDMO business with 10 new clean rooms in Korea

Medipost to expand CDMO business with 10 new clean rooms in Korea

Medipost Co, a South Korean biotechnology company, is expanding its cell and gene therapy contract development and manufacturing organization (CDMO)...

Medipost acquires Canada’s OmniaBio for CDMO business

Medipost acquires Canada’s OmniaBio for CDMO business

Medipost Co., a South Korean biotechnology company, has acquired a 39.6% stake in OmniaBio Inc., a Canada-based cell and gene therapy contract devel...

Kakao Pay backs out of acquisition deal for SSG Pay, Smile Pay Hanwha in talks to buy five-star hotel Paraspara Seoul Kia's Lego-like PV5 with 16 variants to hit market in July Stray Kids make K-pop history with landmark stadium show in Germany S.Korea’s most prominent business leader returns with all charges cleared
banner